Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edgar G Engleman

Showing results (11-20 of 106) with videos related to

Pageof 11
Sort By:
Elife|July 14, 2020
Cancer systems immunologyNathan E Reticker-Flynn, Edgar G Engleman
Clinical and Translational Medicine|July 27, 2025
Hijacking erythropoietin: A tumour-intrinsic strategy to escape immune surveillanceDavid Kung-Chun Chiu, Edgar G Engleman
Human Vaccines & Immunotherapeutics|January 28, 2015
Potential for immunotherapy in soft tissue sarcomaWilliam W Tseng, Neeta Somaiah, Edgar G Engleman
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2010
Plasmacytoid dendritic cell dichotomy: identification of IFN-α producing cells as a phenotypically and functionally distinct subsetPia Björck, H Xianne Leong, Edgar G Engleman
The Journal of Clinical Investigation|March 3, 2004
Induction of potent antitumor immunity by in situ targeting of intratumoral DCsKatsuyoshi Furumoto, Luis Soares, Edgar G Engleman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2005
In vivo manipulation of dendritic cells overcomes tolerance to unmodified tumor-associated self antigens and induces potent antitumor immunityFumiyoshi Okano, Miriam Merad, Katsuyoshi Furumoto, et al.
Blood|February 28, 2002
In vivo manipulation of dendritic cells to induce therapeutic immunityMiriam Merad, Tomoharu Sugie, Edgar G Engleman, et al.
Trends in Immunology|May 16, 2026
Rethinking the origins and functions of adaptive immunityDerick Okwan-Duodu, Erik A Sperling, Edgar G Engleman
Arteriosclerosis, Thrombosis, and Vascular Biology|November 12, 2002
Endothelial determinants of dendritic cell adhesion and migration: new implications for vascular diseasesMichael Weis, Christoph L Schlichting, Edgar G Engleman, et al.
Frontiers in Oncology|July 5, 2016
Hypothesis: The Intratumoral Immune Response against a Cancer Progenitor Cell Impacts the Development of Well-Differentiated versus Dedifferentiated Disease in LiposarcomaWilliam W Tseng, Shefali Chopra, Edgar G Engleman, et al.
Pageof 11

Showing results (11-20 of 106) with videos related to

Sort By:
Pageof 11
Elife|July 14, 2020
Cancer systems immunologyNathan E Reticker-Flynn, Edgar G Engleman
Clinical and Translational Medicine|July 27, 2025
Hijacking erythropoietin: A tumour-intrinsic strategy to escape immune surveillanceDavid Kung-Chun Chiu, Edgar G Engleman
Human Vaccines & Immunotherapeutics|January 28, 2015
Potential for immunotherapy in soft tissue sarcomaWilliam W Tseng, Neeta Somaiah, Edgar G Engleman
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2010
Plasmacytoid dendritic cell dichotomy: identification of IFN-α producing cells as a phenotypically and functionally distinct subsetPia Björck, H Xianne Leong, Edgar G Engleman
The Journal of Clinical Investigation|March 3, 2004
Induction of potent antitumor immunity by in situ targeting of intratumoral DCsKatsuyoshi Furumoto, Luis Soares, Edgar G Engleman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2005
In vivo manipulation of dendritic cells overcomes tolerance to unmodified tumor-associated self antigens and induces potent antitumor immunityFumiyoshi Okano, Miriam Merad, Katsuyoshi Furumoto, et al.
Blood|February 28, 2002
In vivo manipulation of dendritic cells to induce therapeutic immunityMiriam Merad, Tomoharu Sugie, Edgar G Engleman, et al.
Trends in Immunology|May 16, 2026
Rethinking the origins and functions of adaptive immunityDerick Okwan-Duodu, Erik A Sperling, Edgar G Engleman
Arteriosclerosis, Thrombosis, and Vascular Biology|November 12, 2002
Endothelial determinants of dendritic cell adhesion and migration: new implications for vascular diseasesMichael Weis, Christoph L Schlichting, Edgar G Engleman, et al.
Frontiers in Oncology|July 5, 2016
Hypothesis: The Intratumoral Immune Response against a Cancer Progenitor Cell Impacts the Development of Well-Differentiated versus Dedifferentiated Disease in LiposarcomaWilliam W Tseng, Shefali Chopra, Edgar G Engleman, et al.
Pageof 11